Comparison

Interleukin-12p40 (IL12p40)

Item no. 18-731-285098
Manufacturer GENWAY
Amount 0,5 mg
Type Antibody
Applications WB
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-BB4BF8
Similar products 18-731-285098
Available
Genway ID:
GWB-BB4BF8
Immunogen:
Recombinant Human IL12p40 Immunological Activity: Western BlotPH: 7. 2
Buffer:
20mM Phosphate. 150mM Sodium Chloride
Preservative:
0. 09% Sodium Azide
Function:
Cytokine that can act as a growth factor for activated T and NK cells enhance the lytic activity of NK/lymphokine-activated killer cells and stimulate the production of IFN-gamma by resting PBMC.
Function:
Associates with IL23A to form the IL-23 interleukin an heterodimeric cytokine which functions in innate and adaptive immunity. IL-23 may constitute with IL-17 an acute response to infection in peripheral tissues. IL-23 binds to an heterodimeric receptor complex composed of IL12RB1 and IL23R activates the Jak-Stat signaling cascade stimulates memory rather than naive T-cells and promotes production of proinflammatory cytokines. IL-23 induces autoimmune inflammation and thus may be responsible for autoimmune inflammatory diseases and may be important for tumorigenesis.
Subunit:
Heterodimer with IL12A; disulfide-linked. The heterodimer is known as interleukin IL-12. Heterodimer with IL23A; disulfide-linked. The heterodimer is known as interleukin IL-23. Also secreted as a monomer.
Subcellular Location:
Secreted.
Ptm:
Known to be C-mannosylated in the recombinant protein; it is not yet known for sure if the wild-type protein is also modified.
Disease:
Defects in IL12B are a cause of mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950]; also known as familial disseminated atypical mycobacterial infection. This rare condition confers predisposition to illness caused by moderately virulent mycobacterial species such as Bacillus Calmette-Guerin (BCG) vaccine and environmental non-tuberculous mycobacteria and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections with the exception of Salmonella which infects less than 50% of these individuals. The pathogenic mechanism underlying MSMD is the impairment of interferon-gamma mediated immunity whose severity determines the clinical outcome. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood whereas others develop later in life disseminated but curable infections with tuberculoid granulomas. MSMD is a genetically heterogeneous disease with autosomal recessive autosomal dominant or X-linked inheritance.
Similarity:
Belongs to the type I cytokine receptor family. Type 3 subfamily.
Similarity:
Contains 1 fibronectin type-III domain.
Similarity:
Contains 1 Ig-like C2-type (immunoglobulin-like) domain.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0,5 mg
Available: In stock
available

Delivery expected until 9/11/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close